Oxford Biomedica branding over laboratory scene linked to viral vector manufacturing

PARTNERSHIPS

3 Feb 2026

Gene Therapy Grows Up as US Manufacturing Hits Its Stride

A North Carolina facility acquisition highlights a shift toward commercial gene therapy manufacturing as developers seek to reduce supply ...

Itvisma gene therapy packaging and vials used for spinal muscular atrophy treatment

INNOVATION

29 Nov 2025

SMA Gets a Bigger Tool Kit as Gene Therapy Steps Up

Itvisma’s expanded FDA label opens treatment to older SMA patients and hints at broader gene therapy momentum

Digital illustration representing viral vectors delivering genetic material

MARKET TRENDS

25 Nov 2025

Inside the US Rush to Rule Viral Vector Supply

Rising gene therapy demand pushes firms to streamline operations and invest in new platforms

MIT campus building linked to gene therapy and viral vector research

INNOVATION

29 Oct 2025

Crystals That Could Change Gene Therapy

MIT's selective crystallization speeds AAV vector output, cuts costs, and signals a major shift in scalable gene therapy manufacturing

US biotech manufacturing lab expanding viral vector production capacity

INVESTMENT

8 Oct 2025

Investors Eye Carolina as Vector Capacity Expands

Oxford Biomedica’s new US vector site aims to ease shortages and speed gene therapy development

Matica Biotechnology manufacturing facility exterior in the United States

PARTNERSHIPS

16 Sep 2025

New Manufacturing Tie Up Could Lift Gene Therapy Timelines

Matica Bio partners with a clinical stage US biotech to expand vector supply and accelerate an undisclosed gene therapy candidate

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.